The Days of Biosimilars and Molecular Testing Are Here; Are We Ready?: Registration is open for the...
The Days of Biosimilars and Molecular Testing Are Here; Are We Ready?: Registration is open for the NCCN policy summit on September 16 in Washington, DC, which will bring together national health care experts for deliberation on the regulation and application of biosimilars and molecular testing in cancer care
About this item
Full title
Publisher
New York: PR Newswire Association LLC
Journal title
Language
English
Formats
Publication information
Publisher
New York: PR Newswire Association LLC
Subjects
More information
Scope and Contents
Contents
Multiple other biosimilar compounds have been approved or are in development. [...]the use of molecular testing in decision-making to provide personalized medicine for patients with cancer continues to develop as the number of molecular tests that predict risk of disease or benefit of treatment rapidly expands.
Alternative Titles
Full title
The Days of Biosimilars and Molecular Testing Are Here; Are We Ready?: Registration is open for the NCCN policy summit on September 16 in Washington, DC, which will bring together national health care experts for deliberation on the regulation and application of biosimilars and molecular testing in cancer care
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1813158665
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1813158665
